EASY BIO,Inc. (353810.KQ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	525.0B	476.9B	384.3B	165.4B	155.6B
Cost of Revenue	387.6B	355.9B	285.9B	114.5B	108.3B
Gross Profit	137.5B	121.0B	98.5B	50.9B	47.3B
Operating Expenses
R&D Expense	3.3B	3.0B	3.0B	2.5B	2.4B
SG&A Expense	40.8B	25.2B	22.4B	27.2B	27.2B
General & Admin Expense	11.0B	12.7B	9.4B	4.3B	4.1B
Selling & Marketing Expense	9.5B	12.5B	13.0B	11.2B	11.4B
Other Expenses	40.3B	47.8B	40.7B	13.4B	1.5B
Total Operating Expenses	84.3B	76.1B	66.1B	29.7B	31.1B
Cost and Expenses	471.9B	431.9B	351.9B	144.8B	139.4B
Operating Income (EBIT)	53.1B	45.0B	32.4B	20.6B	16.2B
Non-Operating
Interest Income	2.7B	4.4B	3.3B	1.3B	534.5M
Interest Expense	5.8B	10.7B	9.0B	3.2B	1.7B
Net Interest Income	(3.1B)	(6.3B)	(5.7B)	(1.9B)	(1.2B)
Other Non-Op Income/Expense	3.3B	(6.3B)	(6.0B)	(565.6M)	(4.2B)
Non-Operating Income (excl Interest)	(3.5B)	—	(3.0B)	(1.5B)	3.0B
EBT (Pre-Tax Income)	56.4B	38.7B	26.4B	20.1B	12.0B
Income Tax Expense	14.5B	9.4B	6.5B	4.0B	2.6B
Bottom Line
Net Income	39.8B	27.8B	19.6B	15.5B	9.1B
Earnings from Cont. Ops	41.9B	29.3B	19.9B	16.1B	9.3B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	39.8B	27.8B	19.6B	15.5B	9.1B
Per Share
Basic EPS	₩1,204	₩840	₩577	₩455	₩267
Diluted EPS	₩1,204	₩840	₩577	₩455	₩267
Revenue Per Share	₩15,871	₩14,423	₩11,352	₩4,845	₩4,557
Shares
Basic Shares Outstanding	33.1M	33.1M	33.9M	34.1M	34.1M
Diluted Shares Outstanding	33.1M	33.1M	33.9M	34.1M	34.1M
Profitability Metrics
EBITDA	44.6B	53.3B	42.9B	24.3B	16.8B
D&A	8.8B	8.3B	7.5B	3.7B	3.7B
EBIT	35.8B	45.0B	35.4B	20.6B	13.1B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026